AHG Market Analysis
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 7.43
- P/S (TTM)
- 97.24
- EV/EBITDA
- -0.39
Profitability & growth
- ROE (TTM)
- -9.8%
- Operating margin
- -37.5%
- Revenue growth YoY
- -12.9%
- Dividend yield
- —
- Beta
- -1.00
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Akso Health Group ADR
Company profileAkso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NASDAQ
- Country
- China
- Currency
- USD
Company profile
- HQ
- QIANTONGYUAN BUILDING, QINGDAO, CHINA
- Fiscal year end
- March
- Latest quarter
- Dec 31, 2025
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer